Parkman Healthcare Partners LLC trimmed its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 38.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 277,471 shares of the company's stock after selling 172,529 shares during the period. Parkman Healthcare Partners LLC owned about 0.07% of LifeStance Health Group worth $2,045,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently made changes to their positions in LFST. SG Americas Securities LLC grew its stake in LifeStance Health Group by 65.7% in the 4th quarter. SG Americas Securities LLC now owns 90,355 shares of the company's stock valued at $666,000 after buying an additional 35,823 shares in the last quarter. JPMorgan Chase & Co. lifted its position in LifeStance Health Group by 13.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company's stock valued at $662,000 after acquiring an additional 10,894 shares in the last quarter. Jennison Associates LLC grew its stake in shares of LifeStance Health Group by 278.4% in the fourth quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock worth $59,597,000 after acquiring an additional 5,949,438 shares during the period. Principal Financial Group Inc. grew its stake in shares of LifeStance Health Group by 6.1% in the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company's stock worth $28,817,000 after acquiring an additional 235,316 shares during the period. Finally, Handelsbanken Fonder AB bought a new stake in shares of LifeStance Health Group in the fourth quarter worth approximately $128,000. 85.50% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on the stock. Canaccord Genuity Group assumed coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price objective on the stock. William Blair reissued an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. Finally, KeyCorp assumed coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price objective on the stock. One analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, LifeStance Health Group presently has an average rating of "Moderate Buy" and an average price target of $8.30.
View Our Latest Stock Analysis on LifeStance Health Group
LifeStance Health Group Stock Performance
LifeStance Health Group stock traded up $0.01 during mid-day trading on Monday, hitting $5.85. The company had a trading volume of 340,732 shares, compared to its average volume of 1,649,028. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $8.61. The company has a market capitalization of $2.27 billion, a price-to-earnings ratio of -22.48 and a beta of 1.30. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. The company's fifty day moving average is $6.53 and its 200-day moving average is $7.22.
Insider Activity
In other news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the transaction, the insider now owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 3.20% of the company's stock.
About LifeStance Health Group
(
Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Read More
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
